Epidemiology of Diverticulitis in Lung Transplant Recipients

Overview

The purpose of this study is to assess incidence, treatment modalities and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) in order to establish improved treatment strategies in this high risk patient collective.

Full Title of Study: “Long-term Follow-up of Lung Transplant Recipients With Diverticulitis”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: December 2013

Detailed Description

Sigmoid diverticulitis is common and potentially problematic in immunosuppressed patients. The choice between conservative and surgical treatment for uncomplicated diverticulitis remains unclear, as well as the value of the Hartmann's procedure (HP) for complicated diverticulitis. Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing our prospective database of around 400 lung transplant recipients transplanted between 1992 and 2013.

Arms, Groups and Cohorts

  • Lung transplant recipients with uncomplicated diverticulitis
    • Retrospective data analysis of treatment, outcome and recurrency-rate
  • Lung transplant recipients with complicated diverticulitis
    • Retrospective data analysis of treatment, outcome and recurrency-rate

Clinical Trial Outcome Measures

Primary Measures

  • Epidemiology of Diverticulitis in Lung Transplant Recipients
    • Time Frame: January 1992- December 2013 (22 years)
    • Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing a prospective database of around 400 LTRs transplanted between 1992 and 2013.

Participating in This Clinical Trial

Inclusion Criteria

  • Lung transplant recipient – Diverticulitis Exclusion Criteria:

  • none

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Zurich
  • Provider of Information About this Clinical Study
    • Principal Investigator: Nocito Antonio, PD Dr.med. – University of Zurich

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.